Elucidation of potential bortezomib response markers in mutliple myeloma patients

Probability-based protein identification by searching sequence databases using mass spectrometry data

David N. Perkins, Darryl Pappin, David M. Creasy et al. · Electrophoresis · 1999 · 8.2K citations

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION

Joan Bladé, Diana Samson, Donna Reece et al. · British Journal of Haematology · 1998 · 1.5K citations

Plasma lipoproteins: apolipoprotein structure and function.

Robert W. Mahley, T L Innerarity, S C Rall et al. · Journal of Lipid Research · 1984 · 1.2K citations · Full text

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Paul G. Richardson, Hannah Briemberg, Sundar Jagannath et al. · Journal of Clinical Oncology · 2006 · 644 citations · Full text